Company Profiles

driven by the PitchBook Platform

GeneCentric Diagnostics

Description

Developer of molecular diagnostic tests for oncologists and patients. The company engages in developing tests that identifies patients who would benefit from drugs that inhibit tumor growth. It's technology, Cancer Subtype Platform (CSP), identifies sub-types through an integrated analysis of tumor genomics, which leads to to rational clinical trial design, accurate prediction of drug response, efficient target selection in drug development and improved treatment outcomes.

2011

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$6.11M

Latest Deal Amount

$11.4M

Total Amount Raised

Description

Developer of molecular diagnostic tests for oncologists and patients. The company engages in developing tests that identifies patients who would benefit from drugs that inhibit tumor growth. It's technology, Cancer Subtype Platform (CSP), identifies sub-types through an integrated analysis of tumor genomics, which leads to to rational clinical trial design, accurate prediction of drug response, efficient target selection in drug development and improved treatment outcomes.

Website:

www.genecentric.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

280 South Mangum Street Suite 350 Durham, NC 27701United States +1 (919) 973-6544
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore GeneCentric Diagnostics's full profile, request a free trial.

GeneCentric Diagnostics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

GeneCentric Diagnostics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

GeneCentric Diagnostics Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Hatteras Venture PartnersVenture CapitalMinority000 0000000 0000
LabCorp VenturesOtherMinority000 0000000 0000
Hatteras Venture Partners Venture Capital
LabCorp Ventures Other

GeneCentric Diagnostics Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Hawazin Faruki Ph.DChief Scientific Officer
Christy FergusonVice President, Business Development
Myla Lai-Goldman MDCo-Founder, Chief Executive Officer, President & Board Member
Hawazin Faruki Ph.D Chief Scientific Officer
Christy Ferguson Vice President, Business Development
Myla Lai-Goldman MD Co-Founder, Chief Executive Officer, President & Board Member

GeneCentric Diagnostics Board Members (5)

NameRepresentingRoleSinceContact
Info
Arnold Levine Ph.DHatteras Venture PartnersScientific Advisor000 0000
Charles Perou Ph.DGeneCentric DiagnosticsCo-Founder & Board Member000 0000
Clay ThorpHatteras Venture PartnersCo-Founder & General Partner000 0000
David Hayes MDSelfCo-Founder & Board Member000 0000
Myla Lai-Goldman MDSelfCo-Founder, Chief Executive Officer, President & Board Member000 0000
Arnold Levine Ph.D Scientific Advisor Hatteras Venture Partners
Charles Perou Ph.D Co-Founder & Board Member GeneCentric Diagnostics
Clay Thorp Co-Founder & General Partner Hatteras Venture Partners
David Hayes MD Co-Founder & Board Member Self
Myla Lai-Goldman MD Co-Founder, Chief Executive Officer, President & Board Member Self
Request full access to PitchBook